갑상선암 진단 시장 규모, 점유율 및 성장 분석 : 진단 유형별, 암 유형별, 용도별, 최종사용자별, 기술별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)

Global Thyroid Cancer Diagnostics Market size was valued at USD 3.01 Billion in 2024 and is poised to grow from USD 3.16 Billion in 2025 to USD 4.71 Billion by 2033, growing at a CAGR of 5.1% during the forecast period (2026-2033).

The global market for thyroid cancer diagnostics is experiencing significant growth, driven by a rising incidence of thyroid nodules and the adoption of advanced imaging techniques that enhance diagnostic accuracy. Key components include molecular tests, ultrasound technology, and fine needle aspiration cytology, which facilitate timely diagnoses and better treatment outcomes. A shift from traditional cytology to next-generation sequencing, particularly the use of gene expression classifiers, has emerged to reduce unnecessary surgeries associated with indeterminate biopsy results. Furthermore, the integration of payment innovations and technological advancements is accelerating market penetration, as increased reimbursement for molecular tests promotes cost-efficient care. The trend is evident in developing regions, where heightened detection rates lead to local diagnostics production and reduced costs through telepathology support.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Thyroid Cancer Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Thyroid Cancer Diagnostics Market Segments Analysis

Global thyroid cancer diagnostics market is segmented by diagnostic type, cancer type, application, end user, technology, distribution channel and region. Based on diagnostic type, the market is segmented into Imaging Diagnostics, Biopsy-based Diagnostics, Molecular Diagnostics, Laboratory Testing and Others. Based on cancer type, the market is segmented into Papillary Thyroid Cancer, Follicular Thyroid Cancer, Medullary Thyroid Cancer and Anaplastic Thyroid Cancer. Based on application, the market is segmented into Early Cancer Detection, Cancer Staging, Treatment Monitoring, Recurrence Monitoring and Others. Based on end user, the market is segmented into Hospitals, Diagnostic Laboratories, Cancer Research Institutes, Specialty Clinics and Others. Based on technology, the market is segmented into AI-enabled Diagnostic Systems, Next-generation Sequencing, PCR-based Diagnostics, Immunohistochemistry and Others. Based on distribution channel, the market is segmented into Direct Sales, Diagnostic Service Providers and Online Platforms. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Thyroid Cancer Diagnostics Market

One of the key market drivers for the global thyroid cancer diagnostics market is the rising incidence of thyroid cancer worldwide, which has led to an increased demand for advanced diagnostic techniques. Factors such as genetic predisposition, environmental influences, and lifestyle changes are contributing to the growing prevalence of this disease. Additionally, heightened awareness about the importance of early detection and improved healthcare infrastructure are bolstering the market. Technological advancements in imaging and molecular diagnostics further enhance the accuracy and efficiency of thyroid cancer detection, driving investments and clinical focus on innovative diagnostic solutions to cater to the expanding patient population.

Restraints in the Global Thyroid Cancer Diagnostics Market

One significant market restraint in the global thyroid cancer diagnostics sector is the high cost associated with advanced diagnostic technologies and procedures. This financial barrier can limit accessibility for patients, especially in low- and middle-income regions where healthcare budgets are constrained. Moreover, the reimbursement policies for diagnostic tests may not adequately cover the expenses, deterring healthcare providers from adopting the latest diagnostic innovations. Consequently, this can lead to delays in diagnosis and treatment, negatively impacting patient outcomes and limiting overall market growth. Interaction between costs, accessibility, and healthcare policy remains a critical challenge for the industry.

Market Trends of the Global Thyroid Cancer Diagnostics Market

The Global Thyroid Cancer Diagnostics market is experiencing a significant trend towards the adoption of liquid biopsies, driven by advancements in sampling techniques and molecular characterization. This shift facilitates earlier detection of biomarkers and offers enhanced assessment of therapeutic efficacy through continuous monitoring. Consequently, there is a growing push for the standardization of liquid biopsy tests, fostering collaborations between diagnostics companies and clinical laboratories, which enhances accessibility. Clinicians are drawn to the consistency and reduced patient burden these methods provide, while business partners recognize opportunities for workflow optimization through the integration of nucleic acid and protein marker pathways.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Thyroid Cancer Diagnostics Market Size by Diagnostic Type & CAGR (2026-2033)

• Market Overview
• Imaging Diagnostics
  • Ultrasound Imaging
  • CT Imaging
  • MRI Imaging
  • Nuclear Imaging
  • Others
• Biopsy-based Diagnostics
• Molecular Diagnostics
• Laboratory Testing
• Others

Global Thyroid Cancer Diagnostics Market Size by Cancer Type & CAGR (2026-2033)

• Market Overview
• Papillary Thyroid Cancer
• Follicular Thyroid Cancer
• Medullary Thyroid Cancer
• Anaplastic Thyroid Cancer

Global Thyroid Cancer Diagnostics Market Size by Application & CAGR (2026-2033)

• Market Overview
• Early Cancer Detection
• Cancer Staging
• Treatment Monitoring
• Recurrence Monitoring
• Others

Global Thyroid Cancer Diagnostics Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Cancer Research Institutes
• Specialty Clinics
• Others

Global Thyroid Cancer Diagnostics Market Size by Technology & CAGR (2026-2033)

• Market Overview
• AI-enabled Diagnostic Systems
• Next-generation Sequencing
• PCR-based Diagnostics
• Immunohistochemistry
• Others

Global Thyroid Cancer Diagnostics Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Direct Sales
• Diagnostic Service Providers
• Online Platforms

Global Thyroid Cancer Diagnostics Market Size & CAGR (2026-2033)

• North America (Diagnostic Type, Cancer Type, Application, End User, Technology, Distribution Channel)
  • US
  • Canada
• Europe (Diagnostic Type, Cancer Type, Application, End User, Technology, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Diagnostic Type, Cancer Type, Application, End User, Technology, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Diagnostic Type, Cancer Type, Application, End User, Technology, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Diagnostic Type, Cancer Type, Application, End User, Technology, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Roche Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton Dickinson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE HealthCare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myriad Genetics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Veracyte
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Exact Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeoGenomics Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations